financetom
Business
financetom
/
Business
/
Ansys Shares Rise After Synopsys Receives China Regulatory Approval for Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ansys Shares Rise After Synopsys Receives China Regulatory Approval for Acquisition
Jul 14, 2025 10:08 AM

12:37 PM EDT, 07/14/2025 (MT Newswires) -- Ansys ( ANSS ) shares rose by more than 3% in midday Monday trading after Synopsis (SNPS) said has received all necessary regulatory approvals to proceed with its acquisition of the company.

The deal is expected to close on or about Thursday, pending final customary closing conditions, the company said.

Synopsys ( SNPS ) announced on Jan. 16, 2024 that it had agreed to acquire the maker of simulation software in a cash and stock deal worth $35 billion.

Synopsys ( SNPS ) and Ansys ( ANSS ) must meet several conditions set by Chinese regulators, including honoring current contracts and offering electronic design automation tools to Chinese clients on fair, non-discriminatory terms, China's State Administration for Market Regulation said.

They are also required to maintain and renew interoperability agreements with Chinese customers as part of the approval terms, the regulator said.

Price: 386.14, Change: +11.62, Percent Change: +3.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Achieve Life Sciences ( ACHV ) said Thursday it submitted a new drug application to the US Food and Drug Administration for cytisinicline as a treatment for nicotine dependence in smoking cessation. The application is supported by efficacy and safety data from two phase 3 trials, the company said. Separately, Achieve said it...
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) closed an upsized offering of 675 million euros ($789.6 million) in senior secured floating rate notes due Jan. 15, 2031. The notes bear interest at the three-month Euro Interbank Offered Rate plus 3.875%, reset quarterly, the company said Thursday in a statement. The company also completed a...
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Jun 26, 2025
June 26 (Reuters) - Nike ( NKE ) reported a smaller-than-expected drop in fourth-quarter revenue and beat profit estimates on Thursday, as CEO Elliott Hill's strategy to focus product innovation and marketing around sports begins to pay off. The company, which has been grappling with competition in the running space, has heavily invested in running shoes and sneaker lines such...
Copyright 2023-2026 - www.financetom.com All Rights Reserved